☰

Brian M. Andersen, Ph.D. - Publications

Affiliations: 
Neuroscience University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Stem cells
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Moertel CL, Xia J, LaRue R, Waldron NN, Andersen BM, Prins RM, Okada H, Donson AM, Foreman NK, Hunt MA, Pennell CA, Olin MR. CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy. Journal For Immunotherapy of Cancer. 2: 46. PMID 25598973 DOI: 10.1186/S40425-014-0046-9  0.307
2014 Olin MR, Pluhar GE, Andersen BM, Shaver R, Waldron NN, Moertel CL. Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art. Critical Reviews in Immunology. 34: 399-432. PMID 25404047 DOI: 10.1615/Critrevimmunol.2014011577  0.433
2014 Pluhar L, Olin M, Goulart M, Andersen B, Hunt M, Ohlfest J. PM-17INTRACEREBRAL IFN-γ DOES NOT ENHANCE THE RESPONSE TO VACCINE IMMUNOTHERAPY FOR CANINE GLIOMA Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou268.17  0.413
2013 Andersen BM, Pluhar GE, Seiler CE, Goulart MR, SantaCruz KS, Schutten MM, Meints JP, O'Sullivan MG, Bentley RT, Packer RA, Thomovsky SA, Chen AV, Faissler D, Chen W, Hunt MA, et al. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity. Cancer Research. 73: 2987-97. PMID 23471847 DOI: 10.1158/0008-5472.Can-12-3366  0.431
2013 Ohlfest JR, Andersen BM, Litterman AJ, Xia J, Pennell CA, Swier LE, Salazar AM, Olin MR. Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model. Journal of Immunology (Baltimore, Md. : 1950). 190: 613-20. PMID 23248259 DOI: 10.4049/Jimmunol.1201557  0.421
2013 Andersen BM, Pluhar GE, Seiler CE, Xiong Z, Goulart MR, O'Sullivan MG, Hunt MA, Schiaffo CE, Ferguson DM, Ohlfest JR. Abstract B32: Preclinical testing of three immune adjuvants in vaccination therapy for invasive canine meningioma. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B32  0.434
2013 Goulart M, Pluhar E, Andersen B, Seiler C, Hunt M, O'Sullivan G, Zhang Z, Ohlfest J. Abstract B20: Immunotherapy as treatment for dogs with glioma. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B20  0.408
2012 Andersen BM, Ohlfest JR. Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Letters. 325: 155-64. PMID 22809568 DOI: 10.1016/J.Canlet.2012.07.012  0.436
2011 Olin MR, Andersen BM, Litterman AJ, Grogan PT, Sarver AL, Robertson PT, Liang X, Chen W, Parney IF, Hunt MA, Blazar BR, Ohlfest JR. Oxygen is a master regulator of the immunogenicity of primary human glioma cells. Cancer Research. 71: 6583-9. PMID 21908554 DOI: 10.1158/0008-5472.Can-11-1166  0.412
2010 Olin MR, Andersen BM, Zellmer DM, Grogan PT, Popescu FE, Xiong Z, Forster CL, Seiler C, SantaCruz KS, Chen W, Blazar BR, Ohlfest JR. Superior efficacy of tumor cell vaccines grown in physiologic oxygen. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4800-8. PMID 20858839 DOI: 10.1158/1078-0432.Ccr-10-1572  0.407
Show low-probability matches.